Prenetics’ IM8 Partnership to Aid 400,000 Mothers and Children First Year
Prenetics’ IM8 Health will provide prenatal vitamins and supplements to 400,000 underserved mothers and children under five in its first year through a global Vitamin Angels partnership. IM8 reached $100 million in annualized recurring revenue within 11 months and plans to scale impact to millions across Vitamin Angels’ 65-country network.
1. Partnership Objectives
IM8 Health has committed to provide prenatal vitamins, vitamin A supplements and deworming treatments to 400,000 pregnant women, infants and children under five in underserved regions during its first year, leveraging Vitamin Angels’ infrastructure across more than 65 countries.
2. IM8 Performance Metrics
Since launch, IM8 has achieved over $100 million in annualized recurring revenue within 11 months, expanded distribution to 30+ countries and garnered endorsements from high-profile athletes, underlining rapid consumer adoption in the premium nutrition segment.
3. Investor Implications
The partnership enhances Prenetics’ ESG profile and expands IM8’s global footprint, potentially driving future sales growth through heightened brand visibility and access to underserved markets that represent a multibillion-dollar nutrition opportunity.